Trilogy Capital Inc. Amgen Inc Transaction History

Trilogy Capital Inc.

$1.92 Billion
Q3 2024

A detailed history of Trilogy Capital Inc. transactions in Amgen Inc stock. As of the latest transaction made, Trilogy Capital Inc. holds 10,042 shares of AMGN stock, worth $2.66 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

10,042

Previous 10,249 2.02%

Holding current value

$2.66 Million

Previous $3.2 Million 1.03%

% of portfolio

0.17%

Previous 0.18%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $64,041 - $69,837	-207 Reduced 2.02%	10,042 $3.24 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $86,444 - $105,052	329 Added 3.32%	10,249 $3.2 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $96,793 - $116,841	360 Added 3.77%	9,920 $2.82 Million
Q4 2023 Jan 11, 2024	SELL	$255.7 - $288.46 $170,040 - $191,825	-665 Reduced 6.5%	9,560 $2.75 Million
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $2.24 Million - $2.78 Million	10,225 New	10,225 $2.75 Million
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $299,303 - $331,108	-1,365 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $21,876 - $25,036	-110 Reduced 7.46%	1,365 $307,000
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.07%	1,475 $314,000
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $344,296 - $381,972	1,474 New	1,474 $360,000
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $237,823 - $315,418	-1,305 Closed	0 $0
Q3 2019 Oct 07, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.08%	1,305 $255,000
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $23,338 - $27,357	-140 Reduced 9.7%	1,304 $238,000
Q1 2019 Apr 17, 2019	SELL	$180.87 - $203.88 $18,267 - $20,591	-101 Reduced 6.54%	1,444 $274,000
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $35,858 - $41,858	201 Added 14.96%	1,545 $301,000
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $8,708 - $9,817	47 Added 3.62%	1,344 $279,000
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $25,073 - $28,163	151 Added 13.18%	1,297 $239,000
Q1 2018 May 24, 2018	BUY	$169.43 - $198.0 $194,166 - $226,908	1,146 New	1,146 $195,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.

Account

Trilogy Capital Inc. Amgen Inc Transaction History